Myocardial Infarction

Cardiovascular·MeSH: Myocardial Infarction

46 drugs in development·26 companies·9 clinical trials

Drug Pipeline by Phase

Approved(26)

Drug	Company
amlodipine	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
candesartan cilexetil	Aptinyx Inc. (APTX)
carvedilol	Teva Pharmaceutical Industries Limited (TEVA)
clopidogrel bi	Teva Pharmaceutical Industries Limited (TEVA)
clopidogrel bi	DR REDDYS LABORATORIES LTD (RDY)
exforge hct	Novartis AG (NVS)
felodipine	Mylan II B.V. (MYL)
losartan	Mylan II B.V. (MYL)
losartan	Teva Pharmaceutical Industries Limited (TEVA)
nebivolol	ANI PHARMACEUTICALS INC (ANIP)
nexletol	Esperion Therapeutics, Inc. (ESPR)
nexlizet	Esperion Therapeutics, Inc. (ESPR)
norepinephrine bi	Amneal Pharmaceuticals, Inc. (AMRX)
olmesartan medoxomil	Amneal Pharmaceuticals, Inc. (AMRX)
ozempic	Novo Nordisk A/S (NVO)
prasugrel	Mylan II B.V. (MYL)
pravastatin	Aptinyx Inc. (APTX)
spironolactone	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
telmisartan	Inventiva S.A. (IVA)
ticagrelor	DR REDDYS LABORATORIES LTD (RDY)
ticagrelor	Mylan II B.V. (MYL)
ticagrelor	Amneal Pharmaceuticals, Inc. (AMRX)
tirofiban	NEXUS BIOPHARMA INC (NEXS)
valsartan	Mylan II B.V. (MYL)
VASCEPA (VAZKEPA in EU)	AMARIN CORP PLCUK (AMRN)
VASCEPA (VAZKEPA)	AMARIN CORP PLCUK (AMRN)

Phase 3(3)

Drug	Company
Hearticellgram-AMI	CYTOKINETICS INC (CYTK)
Hearticellgram-AMI	Cidara Therapeutics, Inc. (CDTX)
ziltivekimab	Novo Nordisk A/S (NVO)

Phase 2(2)

Drug	Company
cdr132l	Cardiol Therapeutics Inc. (CRDL)
selatogrel	Innovation Pharmaceuticals Inc. (IPIX)

Phase 1(3)

Preclinical(1)

Drug	Company
Instaprin	Aspire Biopharma Holdings Inc. (ASBP)

N/A(6)

Drug	Company
Acetaminophen 1000 mg/d	Structure Therapeutics Inc. (GPCR)
Acetaminophen 4000 mg/d	Structure Therapeutics Inc. (GPCR)
Acetaminophen 4000 mg/d	Cidara Therapeutics, Inc. (CDTX)
Ibuprofen 800 mg/d	Structure Therapeutics Inc. (GPCR)
Ibuprofen 800 mg/d	Cidara Therapeutics, Inc. (CDTX)
Ibuprofen 800 mg/d	PROTHENA CORP PUBLIC LTD CO (PRTA)

Phase 4(5)

Drug	Company
Acetaminophen 1000 mg/d	Filana Therapeutics Inc. (FLNA)
Acetaminophen 4000 mg/d	Filana Therapeutics Inc. (FLNA)
Dapagliflozin 10Mg Tab	Travere Therapeutics, Inc. (TVTX)
Ibuprofen 800 mg/d	Filana Therapeutics Inc. (FLNA)
single	GH Research PLC (GHRS)

BioSniper tracks 46 drugs in development for Myocardial Infarction across 26 companies.

There are 9 clinical trials targeting Myocardial Infarction tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.